Your browser doesn't support javascript.
loading
Early allo-SCT for AML with a complex aberrant karyotype--results from a prospective pilot study.
Schmid, C; Schleuning, M; Tischer, J; Holler, E; Haude, K-H; Braess, J; Haferlach, C; Baurmann, H; Oruzio, D; Hahn, J; Spiekermann, K; Schlimok, G; Schwerdtfeger, R; Buechner, T; Hiddemann, W; Kolb, H-J.
Affiliation
  • Schmid C; Stem Cell Transplantation Unit, Department of Medicine II, Klinikum Augsburg, Ludwig-Maximilians-Universität München, Augsburg, Germany. Christoph.Schmid@klinikum-augsburg.de
Bone Marrow Transplant ; 47(1): 46-53, 2012 Jan.
Article in En | MEDLINE | ID: mdl-21358688

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Antineoplastic Combined Chemotherapy Protocols / Hematopoietic Stem Cell Transplantation / Transplantation Conditioning / Abnormal Karyotype Type of study: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies Language: En Journal: Bone Marrow Transplant Journal subject: TRANSPLANTE Year: 2012 Document type: Article Affiliation country: Germany Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Antineoplastic Combined Chemotherapy Protocols / Hematopoietic Stem Cell Transplantation / Transplantation Conditioning / Abnormal Karyotype Type of study: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies Language: En Journal: Bone Marrow Transplant Journal subject: TRANSPLANTE Year: 2012 Document type: Article Affiliation country: Germany Country of publication: United kingdom